Corrie Studd

Hobart, TAS, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania, Australia.

Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania, Australia.

Journal: Internal medicine journal

Published: May 01, 2018

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: January 03, 2018

Influence of food and lifestyle on the risk of developing inflammatory bowel disease.

Influence of food and lifestyle on the risk of developing inflammatory bowel disease.

Journal: Internal medicine journal

Published: December 14, 2015

Acute gastric dilatation in a bulimic patient.

Acute gastric dilatation in a bulimic patient.

Journal: Gastrointestinal endoscopy

Published: November 26, 2015

Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.

Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.

Journal: Journal of Crohn's & colitis

Published: April 02, 2015

Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.

Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.

Journal: Journal of gastroenterology and hepatology

Published: March 20, 2015

Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia.

Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia.

Journal: Journal of gastroenterology and hepatology

Published: November 17, 2014

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

Journal: The American journal of gastroenterology

Published: June 05, 2014

Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific.

Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific.

Journal: Gut

Published: April 09, 2014

Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.

Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.

Journal: Gastroenterology

Published: January 05, 2013

Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease.

Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease.

Journal: Alimentary pharmacology & therapeutics

Published: September 30, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026